Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

CureVac AG. (2/19/19). "Press Release: CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference". Tübingen & Boston, MA.

Region Region New York, NY
  Country United States (USA)
Organisations Organisation CureVac AG
  Group CureVac (Group)
  Organisation 2 SVB Leerink LLC
Products Product SVB Leerink Annual Global Healthcare Conference 2019 New York
  Product 2 mRNA-based drug
Index term Index term CureVac–Silicon Valley Bank: investor conference, 201902 supply service CureVac presents at SVB Leerink Global Healthcare Conference in NYC
Person Person Menichella, Daniel (Dan) (CureVac 201705– CEO of CureVac Inc before Bamboo Therapeutics + Applied Genetic Technologies)

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 8th Annual Leerink Partners Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 1:50 p.m. ET.

A live broadcast of the presentation will be available at An archived replay of the presentation will be available on the company’s website for approximately 3 months following the presentation.

Record changed: 2019-03-04


Picture [LSUS] – The Business Web Portal 600x60px

More documents for CureVac (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top